ArticleClinical cancer research : an official journal of the American Association for Cancer Research2010

Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment.

Taichi Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.